57views
- CNS Pharmaceuticals Inc CNSP Shares opened Thursday up nearly 21% at $2.14 and ended at $3.02 at 1:35 p.m. EST, a 70% gain.
- However, there is no news to justify such a huge hike.
- Earlier this week, Downs Christopher, CFO of CNS Pharmaceuticals, bought 3,100 shares at an average price of $3.20.
- CEO John M. Climako purchased 15,000 shares on April 14 at an average price of $0.69 per share, and director Jerzy Gumulka purchased 7,173 shares on April 17 at an average price of $0.74.
- Last week, the company said it was able to enroll 100 patients in a potentially pivotal study with berubicin, its lead product candidate for glioblastoma multiforme. An interim analysis is expected in the second quarter.
- Price Action: CNSP shares are up 49.4% at $2.65 last check Thursday.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
add a comment
